Journals / Turkish Journal of Obstetrics and Gynecology / 2020 / Cilt: 17 - Sayı: 4

Pulmonary morbidity related to diaphragm surgery performed for gynecological cancers

Jinekolojik kanser hastalarında yapılan sitoredüktif cerrahiler kapsamında gerçekleştirilen diyafram cerrahilerinin pulmoner morbidite ile ilişkisi

Pages
68–74
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Transdiaphragmatic thoracotomy [odds ratio (OR), 2.66; 95% confidence interval (CI), 1.20-5.92; p=0.016], colon resection (OR, 5.21; 95% CI, 2.34-11.63; p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To evaluate pulmonary morbidity related to diaphragm surgery performed for gynecological cancers and to identify the impact of transdiaphragmatic thoracotomy.
📊
Key Findings & Data:Materials and Methods: We reviewed clinical and pathologic data of 232 women who had undergone diaphragm surgery as a part of cytoreductive surgery procedures performed for gynecological cancers.
💡
Conclusion & Impact:Transdiaphragmatic thoracotomy [odds ratio (OR), 2.66; 95% confidence interval (CI), 1.20-5.92; p=0.016], colon resection (OR, 5.21; 95% CI, 2.34-11.63; p
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To evaluate pulmonary morbidity related to diaphragm surgery performed for gynecological cancers and to identify the impact of transdiaphragmatic thoracotomy. Materials and Methods: We reviewed clinical and pathologic data of 232 women who had undergone diaphragm surgery as a part of cytoreductive surgery procedures performed for gynecological cancers. Results: Transdiaphragmatic thoracotomy occurred in 52 patients (22.4%). Rate of pulmonary complications among patients who had a transdiaphragmatic thoracotomy was higher compared with patients who did not have a transdiaphragmatic thoracotomy (40.4% vs 20.6%, p=0.004). Transdiaphragmatic thoracotomy [odds ratio (OR), 2.66; 95% confidence interval (CI), 1.20-5.92; p=0.016], colon resection (OR, 5.21; 95% CI, 2.34-11.63; p

Özet

Amaç: Jinekolojik kanser hastalarında, sitoreduktif cerrahi kapsamında uygulanan diyafram cerrahisi ile ilişkili pulmoner morbiditenin değerlendirilmesi. Gereç ve Yöntemler: Sitoredüktif cerrahi kapsamında diyafram cerrahisi de uygulanan 232 jinekolojik kanser hastasına ait veriler retrospektif olarak tarandı. Bulgular: Transdiyafram torakotomi 52 (%22,4) hastada oluşmuştu. Transdiyafram torakotomi olan hastalarda herhangi bir pulmoner komplikasyon ortaya çıkma oranı %40,4 iken, transdiyafram torakotomi olmayan hastalarda herhangi bir pulmoner komplikasyon ortaya çıkma oranı %20,6 idi. Transdiyafram torakotomi olan hasta grubunda pulmoner komplikasyon gelişme riskinin daha yüksek olduğu görüldü (p=0,004). Transdiyafram torakotomi [risk oranı (OR), 2,66; %95 güven aralığı (CI), 1,20-5,92; p=0,016], kolon rezeksiyonu (OR, 5,21; %95 CI, 2,34-11,63; p

🔖

Cite This Article

TURAN, T., ÜNSAL, M., BOYRAZ, G., KARALOK, A., DURMUŞ, Y., BORAN, N., ÇÖTELİ, S. A. D. (2022). Pulmonary morbidity related to diaphragm surgery performed for gynecological cancers. Turkish Journal of Obstetrics and Gynecology, Cilt: 17 - Sayı: 4, 68–74. https://ajindex.com/articles/654509

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002;20:1248-59
  2. Chi DS, Eisenhauer EL, Lang J, Huh J, Haddad L, Abu-Rustum NR, et al. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 2006;103:559-64
  3. Papadia A, Morotti M. Diaphragmatic surgery during cytoreduction for primary or recurrent epithelial ovarian cancer: a review of the literature. Arch Gynecol Obstet 2013;287:733-41
  4. Benedetti Panici P, Di Donato V, Fischetti M, Casorelli A, Perniola G, Musella A, et al. Predictors of postoperative morbidity after cytoreduction for advanced ovarian cancer: analysis and management of complications in upper abdominal surgery. Gynecol Oncol 2015;137:406-11
  5. Aletti GD, Dowdy SC, Podratz KC, Cliby WA. Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer. Gynecol Oncol 2006;100:283-7
  6. Alagkiozidis I, Grossman A, Tang NZ, Weedon J, Mize B, Salame G, et al. Survival impact of cytoreduction to microscopic disease for advanced stage cancer of the uterine corpus: a retrospective cohort study. Int J Surg 2015;14:61-6
  7. Solmaz U, Mat E, Dereli ML, Turan V, Ekin A, Tosun G, et al. StageIII and -IV endometrial cancer: a single oncology centre review of 104 cases. J Obstet Gynaecol 2016;36:81-6
  8. Fanfani F, Fagotti A, Gallotta V, Ercoli A, Pacelli F, Costantini B, et al. Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery. Gynecol Oncol 2010;116:497-501
  9. Eisenhauer EL, D’Angelica MI, Abu-Rustum NR, Sonoda Y, Jarnagin WR, Barakat RR, et al. Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced Mullerian cancer. Gynecol Oncol 2006;103:871-7
  10. Devolder K, Amant F, Neven P, van Gorp T, Leunen K, Vergote I. Role of diaphragmatic surgery in 69 patients with ovarian carcinoma. Int J Gynecol Cancer 2008;18:363-8
  11. Chereau E, Rouzier R, Gouy S, Ferron G, Narducci F, Bergzoll C, et al. Morbidity of diaphragmatic surgery for advanced ovarian cancer: retrospective study of 148 cases. Eur J Surg Oncol 2011;37:175-80
  12. Bashir S, Gerardi MA, Giuntoli RL, Montes TPD, Bristow RE. Surgical technique of diaphragm full-thickness resection and trans-diaphragmatic decompression